Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
By activating the ataxia telangiectasia mutated (ATM)-mediated DNA Damage Response (DDR), the AMPK agonist metformin might sensitize cells against further damage, thus mimicking the precancerous stimulus that induces an intrinsic barrier against carcinogenesis. Herein, we present the new hypothesis...
Main Authors: | Menendez, Javier A., Cufí, Sílvia, Oliveras-Ferraros, Cristina, Martin-Castillo, Begoña, Joven, Jorge, Vellon, Luciano, Vazquez-Martin, Alejandro |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249452/ |
Similar Items
-
Gerosuppressant Metformin: less is more
by: Menendez, Javier A., et al.
Published: (2011) -
Metformin: Multi-faceted protection against cancer
by: Del Barco, Sonia, et al.
Published: (2011) -
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
by: Vazquez-Martin, Alejandro, et al.
Published: (2012) -
Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
by: Vazquez-Martin, Alejandro, et al.
Published: (2012) -
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
by: Corominas-Faja, Bruna, et al.
Published: (2012)